Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age (SOM'AJA)

Centre Hospitalier Universitaire de Nice

Status: Enrolling

Conditions: Cancer Survivors

Treatments: Other: Survey of sleep quality and associated factors

Study type: Interventional

Funder types: Other

Identifiers

NCT06904495

25-PP-02

Details and patient eligibility

About

Medical professionals now take into account the specificities of the care and support of Adolescents and Young Adults (AYAs). Cancer aftermaths in patients diagnosed during the AYA period are also known: the consequences of chemotherapy and radiotherapy treatments on a growing organism, the difficulty of some follow-ups, the longevity, and the delayed occurrence of certain complications.

In the general population, sleep disorders affect 40% of adolescents. About 30% of pediatric cancer survivors experience fatigue they attribute to their cancer, even years after the end of their treatment. The sleep quality of patients treated for cancer when they were AYAs, and the eventual care of sleeping disorders, are poorly studied. The investigators suppose that the oncologic treatment during this particular life stage, when sleeping disorders are already present and multifactorial, could have long-term impacts on sleep. The investigators offer to evaluate, through a questionnaire filled out by patients treated for cancer in the AYA period, the frequency of moderate to severe insomnia.

Enrollment: 400 estimated patients

Sex: All

Ages: 15 to 24 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient treated for a cancer
• Patient aged between 15 and 24 years old at the time of the diagnosis
• Patients whom intensive treatment ended at least 3 months ago
• Patient followed in a PACAAURA cancerology center
• Life expectancy ≥ 6 months
• Karnosky index > 60%
• Patient who agrees to participate in the program and benefits from social security
• Patient able to understand, speak and read French.
• No major cognitive impairment (assessed by the patient's referees)
• No sensory disability

Exclusion criteria

• Patient unable to use informatic tools
• Known superior cognitive function disorders
• Progressive psychiatric pathology
• Drug user or alcohol abuse

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

400 participants in 1 patient group

Evaluation of sleep quality

Experimental group

Treatment:

Other: Survey of sleep quality and associated factors